| Company | Lead Banks | Tranche | Price | Purpose | Update |
| Alaska Communications | CIBC World Markets | $50 million revolver | Refi | B loan flexed down from talk of L+225-250 | |
| Bank of America | $335 million term loan | L+200 | |||
| J.P. Morgan | |||||
| CamelBak Group | BNP Paribas | $15 million revolver | L+350 | Dividend | Commitments are due Tues, Jan. 25 |
| Bank of New York | $100 million term loan | L+350 | Recap | Second lien is twice oversubscribed | |
| $37 million second-lien term loan | L+700 | ||||
| Coventry Health Care | Lehman Brothers | $150 million revolver | L+150 | Acqui | Rated Ba1 by Moody’s |
| CIBC World Markets | $300 million A loan | L+150 | |||
| Envirocare of Utah | Calyon | $10 million revolver | L+350 | LBO | In syndication |
| $330 million B loan | L+350 | ||||
| Oreck Corp. | The Royal Bank of Scotland | $20 million revolver | L+300 | Dividend | In syndication |
| $190 million B loan | L+300 | Recap | |||
| Rayovac Corp. | Bank of America | $300 million revolver | L+225 | Acqui | Rated B+ by S&P |
| $740 million B loan | L+225-250 | ||||
| $140 million euro-denominated B loan | L+275 | ||||
| $50 million Canadian dollar-denominated B loan | L+225-250 | ||||
| Wyle Laboratories | Wachovia Securities | $30 million revolver | L+325 | Acqui | In syndication |
| Credit Suisse First Boston | $100 million first-lien term loan | L+325 | |||
| $50 million second-lien term loan | L+650 | ||||
| The Primary Roundup is a compilation of updates on deals previously reported by LMW, as of Thurs, Jan. 20. |